We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Stem Cell Protein Promotes Formation of New Blood Vessels in Aggressive Breast Cancer

By LabMedica International staff writers
Posted on 16 Aug 2012
A protein that functions in the developing embryo and is characteristic of embryonic stem cells (ESCs) has been found also to be active in an aggressive form of breast cancer where it promotes development of new blood vessels for the rapidly growing tumor.

Investigators at the University of Western Ontario (London, Canada) focused their research on the Nodal protein. More...
Nodal is a member of the TGF-beta protein superfamily. Studies of the mouse counterpart of this protein have suggested that this protein may be essential for mesoderm formation and subsequent organization of axial structures in early embryonic development. Nodal does not function in mature normal cells.

The investigators reported in the August 1, 2012, online edition of the journal Cancer Research that high levels of Nodal positively correlated with high vascular densities in human breast lesions. In vitro, Nodal facilitated breast cancer–induced endothelial cell migration and tube formation, largely by upregulating the expression and secretion of factors that promoted formation of new blood vessels by the breast cancer cells. Results of a directed in vivo angiogenesis assay and a chick chorioallantoic membrane assay showed that Nodal promoted vascular recruitment in vivo.

By using genomic techniques to inhibit Nodal expression following tumor formation in a mouse breast cancer model, the investigators induced significant reduction in tumor vascularization together with elevated hypoxia and tumor necrosis.

"We have determined that breast cancers, specifically those very aggressive, invasive breast cancers that spread, express an embryonic protein called Nodal and the expression of this protein is correlated with more blood vessels in the tumor. Blood vessels, many studies have shown, help to allow tumors to grow but also to spread throughout the body," said senior author Dr. Lynne-Marie Postovit, professor of anatomy and cell biology at the University of Western Ontario. "In addition, we have shown that if we can target this embryonic protein, we can cause the blood vessels to collapse within the tumor, leading to decreased oxygen levels and tumor cell death. When tumors lack oxygen and nutrients they become what we call necrotic."

Related Links:
University of Western Ontario



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HPV Test
Allplex HPV28 Detection
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.